Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1

Conditions

Prostatic Neoplasms 1 Meningeal Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

pembrolizumab 141 Nivolumab 117 Ipilimumab 69 Cyclophosphamide 34 Specimen Handling 30 Magnetic Resonance Spectroscopy 28 trametinib 23 fludarabine 22 binimetinib 22 Interleukin-2 21 dabrafenib 19 relatlimab 17 encorafenib 17 Biopsy 17 aldesleukin 16 CTLA-4 Antigen 16 fludarabine phosphate 15 cemiplimab 15 atezolizumab 15 Radiosurgery 15 Opdualag 14 Radiotherapy 11 lifileucel 10 lenvatinib 10 Blood Specimen Collection 10 spartalizumab 8 Paclitaxel 8 Cisplatin 8 Bevacizumab 8 cobimetinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × gadopiclenol × 1 year × Clear all

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡